Virtual Reality (VR) Self-Hypnosis Software
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIcahn School of Medicine at Mount Sinai
About this trial
This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGo™) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.
Eligibility criteria
Qualifiers
Adults age ≥18
Confirmed diagnosis of HIV, currently on a stable antiretroviral regimen ≥ 90 days.
Documentation of chronic pain associated with HIV for≥90 days
Stable pain management regimen ≥90 days, or no pain treatments ≥90 days
Disqualifiers
A co-occurring medical or psychiatric condition which would make participation in the study or complicate measurement of changes associated with the intervention.
Concurrent participation in another investigational protocol for pain treatment
A psychiatric disorder, medical condition, or other life circumstance, which in the opinion of the PI, would contraindicate attendance at sessions, or make it unlikely that the participant could successfully complete the study procedures.
Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological conditions contraindicating the use of virtual reality devices.
Trial design
Treatments tested in this trial
- Virtual Reality headset
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov